General Information of Drug (ID: DMYXA7E)

Drug Name
FdG Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMYXA7E

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AT-527 DMARIQK Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [2]
Pyrophosphate 2- DMZQ75M Discovery agent N.A. Investigative [3]
Guanosine-5'-Triphosphate DMV2OJX Discovery agent N.A. Investigative [4]
Thiadiazolo[2,3-a]pyrimidine DMKRG2C Discovery agent N.A. Investigative [1]
T-1105 DMGPQ0Y Discovery agent N.A. Investigative [1]
Pyrimidinyl acylthiourea DM7T2VQ Discovery agent N.A. Investigative [1]
T-1106 DMPA2E9 Virus infection 1A24-1D9Z Investigative [1]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Virus RNA-dependent RNA polymerase (Viru RdRP) TTSUKYD POLG_HCVJA Inhibitor [1]

References

1 Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrob Agents Chemother. 2009 Jan;53(1):202-9.
2 AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19. Antimicrob Agents Chemother. 2021 Mar 18;65(4):e02479-20.
3 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
4 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.